The first-in-man bioengineered artificial tracheobronchial transplant consisting of a synthetic scaffold and autologous bone marrow-derived mesenchymal cells was recently reported. Extensive evaluation of the patient before and after transplant provides some insight into the potential mechanisms of stem cell mobilization and tracheal tissue regeneration.
Copyright 2012 Elsevier B.V., All rights reserved.
- Autologous cell therapy
- Bioartificial organs
- Tracheal transplant